SCHEMBL1888076

SCHEMBL1888076

COc1ccc(-c2nc(C)nc(Cl)c2N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
NPSR1 Q6W5P4 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
ADORA2A P29274 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KDM4E B2RXH2 2/20 0.50
LMNA P02545 2/20 0.50
ADORA1 P30542 2/20 0.48
PDCD1 Q15116 1/20 0.47
CD274 Q9NZQ7 1/20 0.47
MAPT P10636 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.47
DPP4 P27487 1/20 0.46
KMT2A Q03164 2/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 1/20 0.44
DHPS P49366 1/20 0.43
TNK2 Q07912 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1892740 0.85 ADORA2A (0.59) ALDH1A1NPSR1TDP1ADORA2AL3MBTL1
SCHEMBL11468071 0.83 ADORA2A (0.49) ALDH1A1NPSR1TDP1ADORA2AL3MBTL1
SCHEMBL4647035 0.83 KDM4E (0.59) ALDH1A1TDP1ADORA2AL3MBTL1KDM4E
SCHEMBL10444906 0.79 ALDH1A1 (0.58) ALDH1A1NPSR1TDP1L3MBTL1KDM4E
SCHEMBL1887389 0.75 KMT2A (0.51) ALDH1A1NPSR1TDP1KDM4ELMNA
SCHEMBL1886173 0.75 MERTK (0.43) ALDH1A1NPSR1TDP1L3MBTL1KDM4E
SCHEMBL28872938 0.74 ADORA2A (0.70) ALDH1A1NPSR1TDP1ADORA2AL3MBTL1
SCHEMBL13578943 0.74 NR4A1 (0.51) ALDH1A1NPSR1TDP1L3MBTL1KDM4E
SCHEMBL17528562 0.73 KDR (0.59)
SCHEMBL178633 0.72 DPP4 (0.57) ALDH1A1NPSR1TDP1ADORA2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105543-A1 NOVEL TRIARYL DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS NEUROSEARCH A/S (DK) 2011-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105543-A1 NOVEL TRIARYL DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA5, CHRNA3, CHRM3 ALDH1A1 2700/4885NPSR1 27/4885TDP1 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.